These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19006444)

  • 1. A bleak future for independent community pharmacy under Medicare Part D.
    Spooner JJ
    J Manag Care Pharm; 2008; 14(9):878-81. PubMed ID: 19006444
    [No Abstract]   [Full Text] [Related]  

  • 2. The challenge of Medicare Part D for community pharmacies.
    Stone D
    J Manag Care Pharm; 2009 Mar; 15(2):171-2. PubMed ID: 19236134
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacies and population health.
    Lavigne JE; Wright SA; Burke ES; Kirwan B; Ball J
    Am J Health Syst Pharm; 2017 Oct; 74(19):1522-1523. PubMed ID: 28947521
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding the effects of Medicare Part D from key stakeholders' perspectives: Important progress, but abundant research opportunities remain.
    Urmie JM; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):85-9. PubMed ID: 20511107
    [No Abstract]   [Full Text] [Related]  

  • 7. Navigating financial assistance options for patients receiving specialty medications.
    Schwieterman P
    Am J Health Syst Pharm; 2015 Dec; 72(24):2190-5. PubMed ID: 26637519
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a pharmacist reduce annual costs for Medicare Part D enrollees?
    Alston G; Hanrahan C
    Consult Pharm; 2011 Mar; 26(3):182-9. PubMed ID: 21402518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
    Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
    Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
    Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435
    [No Abstract]   [Full Text] [Related]  

  • 14. To Reform Pharmacy Reimbursement Begin with the Basics.
    Rupp MT
    J Manag Care Spec Pharm; 2020 Jun; 26(6):713-715. PubMed ID: 32463772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
    Carroll NV
    J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare Reform: Administrative Rulemaking.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-47. PubMed ID: 28248472
    [No Abstract]   [Full Text] [Related]  

  • 18. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of the Medicare Part D prescription benefit on generic drug use.
    Zhang JX; Yin W; Sun SX; Alexander GC
    J Gen Intern Med; 2008 Oct; 23(10):1673-8. PubMed ID: 18661190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Part D shuffle. UnitedHealth, Humana lose business.
    Vesely R
    Mod Healthc; 2007 Oct; 37(40):17. PubMed ID: 18018374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.